United Therapeutics Corporation

2024年2月21日 — United Therapeutics said on Wednesday it had filed a case with the U.S. Food and Drug Administration, alleging that due procedure was not ...

United Therapeutics' (UTHR) fourth-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the company's top line.

United Therapeutics is a biotechnology company focused on creating unique products to address the medical needs of patients with chronic illnesses.

Our next-generation therapies are designed to address the unmet needs of patients living with conditions such as PAH, PH, and end-stage organ disease. VISION.

United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR.

Our purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability ...

Investor Resources for Pharmaceutical and Biotech Investment at United Therapeutics Corporation.

United Therapeutics Corporation · UTHR ; 聯合治療公司 · Nasdaq ; 1000 Spring St,Silver Spring,Maryland 20910,United States Of America · http://www.unither.com.